Codexis (CDXS) News Today $5.28 +0.16 (+3.13%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Codexis (NASDAQ:CDXS) Stock Price Passes Above 200-Day Moving Average - Time to Sell?Codexis (NASDAQ:CDXS) Shares Cross Above 200-Day Moving Average - Here's What HappenedDecember 19 at 4:07 AM | marketbeat.comCodexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last weekDecember 14, 2024 | finance.yahoo.comJacobs Levy Equity Management Inc. Sells 114,194 Shares of Codexis, Inc. (NASDAQ:CDXS)Jacobs Levy Equity Management Inc. lessened its holdings in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 11.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 895,695 shares of thDecember 8, 2024 | marketbeat.comCodexis Announces New Employment Inducement GrantsDecember 6, 2024 | globenewswire.comFred Alger Management LLC Lowers Holdings in Codexis, Inc. (NASDAQ:CDXS)Fred Alger Management LLC lowered its stake in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 64.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 125,916 shares of the biotechnology company's stockDecember 2, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Short Interest Down 13.8% in NovemberCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 1,680,000 shares, a decline of 13.8% from the October 31st total of 1,950,000 shares. Based on an average daily volume of 661,400 shares, the short-interest ratio is currently 2.5 days.December 1, 2024 | marketbeat.comCantor Fitzgerald Keeps Their Buy Rating on Codexis (CDXS)November 23, 2024 | markets.businessinsider.comCodexis (NASDAQ:CDXS) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $11.00 target price on shares of Codexis in a research report on Friday.November 22, 2024 | marketbeat.comCodexis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNovember 19, 2024 | globenewswire.comStifel Nicolaus Remains a Buy on Codexis (CDXS)November 15, 2024 | markets.businessinsider.comCodexis (CDXS) Receives a Hold from TD CowenNovember 15, 2024 | markets.businessinsider.comCodexis (NASDAQ:CDXS) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $11.00 price objective on shares of Codexis in a report on Friday.November 15, 2024 | marketbeat.comCodexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi TherapeuticsNovember 14, 2024 | globenewswire.comBaillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS)Baillie Gifford & Co. lessened its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 33.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,813,800 shares of the biotechnology company's stocNovember 14, 2024 | marketbeat.comCodexis, Inc.: Codexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNovember 13, 2024 | finanznachrichten.deCodexis Strengthens Board and Updates BylawsNovember 13, 2024 | markets.businessinsider.comCodexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNovember 12, 2024 | globenewswire.comCodexis (CDXS) Gets a Buy from Craig-HallumNovember 12, 2024 | markets.businessinsider.comCodexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi TherapeuticsNovember 11, 2024 | globenewswire.comCodexis Announces New Employment Inducement GrantsNovember 8, 2024 | globenewswire.comabrdn plc Raises Position in Codexis, Inc. (NASDAQ:CDXS)abrdn plc lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 62.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 800,410 shares of the biotechnology company's stock after acquiring an additional 307,762 shares during the quartNovember 5, 2024 | marketbeat.comCodexis to Participate in Upcoming Healthcare ConferencesNovember 4, 2024 | globenewswire.comCodexis' (CDXS) Hold Rating Reiterated at BenchmarkBenchmark reissued a "hold" rating on shares of Codexis in a research report on Monday.November 4, 2024 | marketbeat.comCodexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 3, 2024 | finance.yahoo.comCodexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17November 3, 2024 | finance.yahoo.comCodexis (CDXS) Receives a Buy from Stifel NicolausNovember 1, 2024 | markets.businessinsider.comCodexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ...November 1, 2024 | finance.yahoo.comCodexis Reports Strong Q3 Revenue GrowthNovember 1, 2024 | markets.businessinsider.comCodexis: Hold Rating Amid Mixed Market Position and Future Growth ProspectsNovember 1, 2024 | markets.businessinsider.comCodexis Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS)Assenagon Asset Management S.A. boosted its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 23.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,103,442 shares of the biotechnology company's stock after purchasing an adOctober 31, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Short Interest UpdateCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 2,000,000 shares, a decrease of 11.5% from the September 30th total of 2,260,000 shares. Based on an average daily trading volume, of 552,700 shares, the short-interest ratio is currently 3.6 days.October 29, 2024 | marketbeat.comCodexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual MeetingOctober 24, 2024 | globenewswire.comCodexis (CDXS) to Post Quarterly Earnings on ThursdayCodexis (NASDAQ:CDXS) will be releasing earnings after the market closes on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634762)October 24, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedCodexis (NASDAQ:CDXS) Stock Crosses Above Two Hundred Day Moving Average - Here's What HappenedOctober 22, 2024 | marketbeat.comCodexis announces employment inducement grantsOctober 15, 2024 | finance.yahoo.comCodexis Announces New Employment Inducement GrantsOctober 14, 2024 | globenewswire.comCodexis to Report Third Quarter 2024 Financial Results on October 31October 10, 2024 | globenewswire.comCodexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...October 9, 2024 | gurufocus.comCodexis secures $31 million to extend cash runwayOctober 4, 2024 | uk.investing.comCodexis appoints new CTO and CFOOctober 4, 2024 | investing.comCodexis (CDXS) Receives a Buy from Craig-HallumOctober 4, 2024 | markets.businessinsider.comCodexis Names Georgia Erbez as CFOOctober 2, 2024 | marketwatch.comCodexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyOctober 2, 2024 | globenewswire.comCodexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciencesOctober 1, 2024 | globenewswire.comNantahala Capital Management LLC Sells 832,256 Shares of Codexis, Inc. (NASDAQ:CDXS)Nantahala Capital Management LLC cut its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 18.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,629,622 shares of the biotechnology company's stock after selling 832,256 shares during theOctober 1, 2024 | marketbeat.comFred Alger Management LLC Has $1.08 Million Stock Position in Codexis, Inc. (NASDAQ:CDXS)Fred Alger Management LLC decreased its holdings in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 31.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 349,490 shares of the biotechnology company'sSeptember 28, 2024 | marketbeat.comOpaleye Management Inc. Buys 5,000 Shares of Codexis, Inc. (NASDAQ:CDXS) StockSeptember 27, 2024 | insidertrades.comOpaleye Management Inc. Expands Stake in Codexis Inc.September 24, 2024 | gurufocus.comOpaleye Management Inc. Purchases 45,000 Shares of Codexis, Inc. (NASDAQ:CDXS) StockSeptember 24, 2024 | insidertrades.com Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol CDXS Media Mentions By Week CDXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼0.780.60▲Average Medical News Sentiment CDXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼12▲CDXS Articles Average Week Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLDX News MNKD News DVAX News BCRX News NVAX News MYGN News INVA News OPK News IRWD News SGMO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Codexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXS Stock Alerts